Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCB1 | P08183 | 1/20 | 0.44 |
| ▸ | ACHE | P22303 | 13/20 | 0.43 |
| ▸ | MAOA | P21397 | 2/20 | 0.38 |
| ▸ | MAOB | P27338 | 2/20 | 0.38 |
| ▸ | TCF4 | P15884 | 1/20 | 0.32 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.32 |
| ▸ | PREP | P48147 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7101088 | 0.77 | ACHE (0.64) | ABCB1ACHETCF4CTNNB1 | |
| SCHEMBL16593838 | 0.75 | PTK2 (0.39) | ABCB1PREP | |
| SCHEMBL5951741 | 0.75 | ACHE (0.49) | ABCB1ACHEMAOAMAOB | |
| SCHEMBL5952518 | 0.74 | ABCB1 (0.46) | ABCB1ACHEMAOAMAOB | |
| SCHEMBL5951589 | 0.74 | ABCB1 (0.50) | ABCB1ACHEMAOAMAOB | |
| SCHEMBL5952900 | 0.74 | ACHE (0.48) | ABCB1ACHEMAOAMAOB | |
| SCHEMBL5951611 | 0.72 | ACHE (0.47) | ABCB1ACHEMAOAMAOB | |
| SCHEMBL5951784 | 0.71 | DRD2 (0.56) | ABCB1ACHE | |
| SCHEMBL5951938 | 0.71 | ABCB1 (0.46) | ABCB1ACHEMAOAMAOB | |
| SCHEMBL5951495 | 0.71 | ACHE (0.52) | ABCB1ACHEMAOAMAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1401880-B1 | METALLOCENE CATALYSTS CONTAINING AN INDENYL MOIETY SUBSTITUTED AT THE 4-, 5-, 6- OR 7-POSITION BY A SILOXY OR GERMYLOXY GROUP | BOREALIS TECH OY (FI) | 2010-11-10 | — | — | EP | disclosed |
| US-7074863-B2 | Metallocene catalysts containing an idenyl moiety substituted at the 4,-5,-6- or 7-position by a siloxy or germyloxy group | BOREALIS TECHNOLOGY OY (FI) | 2006-07-11 | — | — | US | disclosed |
| US-20040152882-A1 | Metallocene catalysts containing an idenyl moiety substituted at the 4,-5,-6- or 7-position by a siloxy or germyloxy group | BOREALIS TECHNOLOGY OY (FI) | 2004-08-05 | — | — | US | disclosed |
| EP-1401880-A1 | METALLOCENE CATALYSTS CONTAINING AN INDENYL MOIETY SUBSTITUTED AT THE 4-, 5-, 6- OR 7-POSITION BY A SILOXY OR GERMYLOXY GROUP | Borealis Technology Oy (FI) | 2004-03-31 | — | — | EP | disclosed |
| WO-2003000744-A1 | METALLOCENE CATALYSTS CONTAINING AN IDENYL MOIETY SUBSTITUTED AT THE 4-, 5-, 6- OR 7-POSITION BY A SILOXY OR GERMYLOXY GROUP | BOREALIS TECHNOLOGY OY (FI) | 2003-01-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040152882-A1 | Metallocene catalysts containing an idenyl moiety substituted at the 4,-5,-6- or 7-position by a siloxy or germyloxy group | IPO4, GEMIN4, GEMIN5 | ABCB1 2146/4885ACHE 3443/4885MAOA 3667/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.